Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

Nepal Ausadhi Limited has been awarded with the Good Manufacturing Practice (GMP) certificate, meeting the World Health ...

Kolkata: The West Bengal health dept asked a saline manufacturing unit, which is a major supplier to govt hospitals, to stop manufacturing the product.

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

AmplifyBio, a leading preclinical CRO and CDMO played a pivotal role in shaping discussions at Phacilitate’s Advanced Therapy ...

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

“A key objective for Secretome in 2025 is to produce STM-01 drug product that is suitable for late-stage clinical testing and potential commercial use,” said Vinny Jindal, President and CEO of ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.

Atara said it has discussed and agreed with the FDA “upon the actions necessary to release the clinical holds”. Image credit: Shutterstock / Lamar Belina. Atara Therapeutics’ pipeline has hit another ...